FDA solicits recall comments
This article was originally published in The Tan Sheet
FDA asks companies disgruntled by its current recall regulations to air their grievances and suggest changes to the agency by Aug. 4, according to a June 3 Federal Register notice. Specifically, FDA requests feedback on whether firms believe the agency accurately estimates the time and cost for companies to develop a recall strategy, initiate a recall and recall communications, and complete related reports...
You may also be interested in...
Moderna is speculated to be in talks with Indian firms, including Wockhardt and a Tata group company, for manufacturing its COVID-19 vaccine. A deal in India could help the company meet its obligation to supply COVAX but Moderna is likely to choose its partner carefully.
Trade group AdvaMed should be consulted on how to implement the Defense Production Act to boost testing and PPE production, CEO Scott Whitaker said in a letter to President Biden.
Following a successful offering by Prestige BioPharma in January, investors will keep their focus on another upcoming major listing by the SK Group's specialist vaccines arm SK Bioscience, which is likely to set the tone for the South Korean biopharma IPO market this year.